InQpharm Group
Pre-Approval PRO BETAInactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 6/1/2014
Pipeline by Phase
Therapeutic Focus
Clinical Trials (15)
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
Started: 7/1/2013
Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections
Started: 10/1/2013
Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects
Started: 6/1/2014
Efficacy and Safety of IQP-VV-102 in Weight Management
Started: 10/1/2012
Efficacy and Safety of Zenoctil in Reducing Body Weight
Started: 7/1/2011
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
Started: 1/1/2014
IQP-PO-101 for the Regulation of Bowel Movement Frequency
Started: 3/1/2013
Safety and Efficacy of Litramine in Overweight and Obese Subjects
Started: 7/1/2010
Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects
Started: 5/1/2011
Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn
Started: 10/1/2012
Efficacy and Safety of Glucosanol in Maintaining Body Weight
Started: 9/1/2011